Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colon Cancer|Ovarian Cancer|Endometrium Cancer
Interventions: DRUG: BKM120
Sponsor: Novartis Pharmaceuticals